B7-H1 Determines Accumulation and Deletion of Intrahepatic CD8+ T Lymphocytes  by Dong, Haidong et al.
Immunity, Vol. 20, 327–336, March, 2004, Copyright 2004 by Cell Press
B7-H1 Determines Accumulation and Deletion
of Intrahepatic CD8 T Lymphocytes
tive negative signal (Salomon and Bluestone, 2001). In
recent years, new members of the B7 family have been
identified (Carreno and Collins, 2002), and functional
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important regulatory functions in cell-mediated and hu-
moral immune responses. B7-H1 was identified by EST
database searches based on its homology to the B7sSummary
(Dong et al., 1999). Although B7-H1 mRNA is found in
many tissues and cells, surface expression of this pro-Upon systemic activation by antigens, CD8, but not
tein is rare. Immunohistochemistry analysis by a specificCD4, T cells selectively accumulate and undergo apo-
B7-H1 monoclonal antibody (mAb) has shown that liverptosis in the liver, a mechanism associated with the
Kupffer cells and other monocyte-derived cells as wellinduction of hepatic tolerance and chronic infection.
as epithelial and endothelial cells constitutively expressThe molecular basis for CD8 T cell preference in this
B7-H1 (Dong et al., 2002; Selenko-Gebauer et al., 2003;process is unknown. We prepared B7-H1-deficient
Brown et al., 2003; Iwai et al., 2003).mice by gene targeting and found spontaneous accu-
The second ligand, B7-DC, was cloned by a sub-mulation of CD8 T cells in the liver while CD4 T cell
tractive hybridization method searching for dendriticlevels remained normal. Moreover, antigen-driven
cell-specific transcripts (Tseng et al., 2001). Both B7-H1CD8 T cells proliferated normally while apoptotic lev-
and B7-DC are capable of binding to the PD-1 receptorels during the contraction phase was selectively im-
(Freeman et al., 2000; Latchman et al., 2001). PD-1-paired in the liver, leading to accelerated hepatocyte
deficient mice spontaneously develop systemic and or-damage in experimental autoimmune hepatitis. There-
gan-specific autoimmune diseases (Nishimura et al.,fore, B7-H1 is a key protein selectively regulating the
1999), and administration of antagonistic monoclonalaccumulation and deletion of intrahepatic CD8 T cells
antibodies (mAb) to PD-1 accelerates ongoing autoim-and may also contribute to inflammation, autoimmune
mune diseases (Salama et al., 2003; Ansari et al., 2003).diseases, and tolerance in the liver.
These results support a role for PD-1 in negatively con-
trolling T cell responses. While both B7-H1 and B7-DCIntroduction
were found to be inhibitory for activated T cells (Freeman
et al., 2000; Latchman et al., 2001), several independentThe liver is an important organ in the regulation of
laboratories have shown that B7-H1 and B7-DC wereT cell homeostasis, tolerance, and death and intrahe-
costimulatory for naive T cells (Dong et al., 1999; Tsengpatic T cell responses to pathogens. Immune responses
et al., 2001). An additional receptor(s) mediating the co-in the liver often lead to tolerance. This is best illustrated
stimulatory effect of B7-H1 and B7-DC has been impli-by the high acceptance rate of liver transplants without
cated (Dong et al., 2002) and is best indicated by theimmunosuppression (Wick et al., 2002; Crispe, 2003).
fact that mutants of B7-H1 and B7-DC, incapable of
The liver also has the remarkable ability to control the
binding PD-1, remain costimulatory for PD-1/ T cells
apoptosis of activated T cells. Exposure to blood-borne
(Wang et al., 2003). Also, both B7-H1 and B7-DC can
antigens often induces systemic activation of antigen- costimulate PD-1/ T cells in vitro and in vivo (Wang
specific CD8 T cells that subsequently accumulate and et al., 2003; Liu et al., 2003; Shin et al., 2003).
get deleted in the liver. These findings could be interpre- Furthermore, B7-H1 has been implicated in the apo-
ted either as preferential accumulation in the liver of ptotic regulation of activated T cells during cancer pro-
activated T cells undergoing apoptosis (the graveyard gression. B7-H1 is constitutively expressed on the ma-
hypothesis) or a trap for activated T cells in the liver for jority of human cancers (Dong and Chen, 2003), and
subsequent killing (the killing field hypothesis) (Crispe this tumor-associated B7-H1 promotes the apoptosis
et al., 2000; Crispe, 2003). The molecular mechanisms of activated human T cells in vitro and increases the
underlying these observations have not yet been eluci- resistance of B7-H1 mouse tumors to T cell attack
dated. (Dong et al., 2002). In this study, we examined the physi-
B7-like molecules and their cognate receptors consti- ological relevance of B7-H1 by using a mouse model of
tute important costimulatory pathways that control and gene inactivation. We report here the unexpected find-
fine-tune immune responses. The classical B7-CD28 ing that B7-H1 plays a central role in the selective dele-
pathway includes two ligands, CD80 and CD86, and at tion of CD8 T cells in the liver.
least two receptors, CD28 and CTLA-4. Costimulation
by engaging CD28 promotes growth, prevents anergy, Results
and enhances the survival of T cells. In contrast, ligation
to CTLA-4 inhibits T cell responses by delivering a puta- Generation of B7-H1-Deficient (KO) Mice
B7-H1 KO mice were generated by homologous recom-
bination in 129 embryonic stem (ES) cells. Our gene-*Correspondence: chen.lieping@mayo.edu
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Figure 1. Generation of B7-H1 KO Mice
(A) The targeting map of B7-H1 genomic lo-
cus. The signal peptide with the ATG starting
code and a large portion of exon 2 encoding
the IgV domain of B7-H1 were replaced with
Neo cassette. A short bold black bar indicates
the position of 3 end probe, and arrows indi-
cate the position of PCR primers. The enzyme
sites are indicated as X, XhoI; S, SpeI; P, PstI;
EV, EcoRV; E, EcoRI.
(B) Southern blot and PCR detection of het-
erozygous and homozygous B7-H1 mutants
in the genomic DNA from targeted embryo
stem (ES) cells and mouse tails.
(C) Flow cytometry analysis of B7-H1 expres-
sion on the surface of activated CD4 T cells
from wt or KO mice with control antibody
(open lines) or anti-B7-H1 mAb (filled lines).
targeting vector replaced exon 1 and a large part of T cell populations in the spleen and lymph nodes also
appeared in normal numbers, indicating that B7-H1exon 2 in the endogenous B7-H1 allele with a Neo-
resistance cassette (Figure 1A), thereby deleting the se- might not affect T cell development in lymphoid organs
(Figure 2A). There was also no evidence of autonomousquences encoding the signal peptide and the majority
of the extracellular IgV domain of B7-H1 (Wang et al., activation of T cells, judging by expression of CD62L
and CD25 (data not shown). In contrast, the total number2003). Among 394 G418-resistant ES clones, nine (2.3%)
displayed a correctly targeted B7-H1 allele (Figure 1B). of lymphocytes in the liver was significantly higher in
B7-H1 KO mice than in wt mice. While we often observedChimeric male mice were derived from these ES clones
by standard procedures. They were crossed to C57BL/6 slightly increased intrahepatic CD4 T cell counts in
B7-H1 KO mice, the differences between the KO and wtfemales, and heterozygous mutant mice were estab-
lished from two independently targeted ES clones. Het- mice were often insignificant. In contrast, CD8 T cells
increased dramatically (Figures 2B and 2C). As a result,erozygous or homozygous B7-H1 mutant mice were
then identified by PCR analysis of genomic DNA isolated the average ratio of intrahepatic CD8 to CD4 T cells
increased from 0.46 in wt mice to 1.6 in KO mice. Therefrom tail biopsies (Figure 1B). To confirm the absence
of the B7-H1 protein in these mice, anti-CD3/CD28 acti- was no difference in the number of intrahepatic B220
B cells (25%) in B7-H1 KO mice as compared to wt micevated CD4 cells from B7-H1 KO mice were stained with
B7-H1 mAb (Dong et al., 2002). As expected, B7-H1 was (27%). Similarly, a significant increase of CD8 T cells
was found in the kidney (9.4% in KO mice versis 3.2%detected in wt but not in B7-H1 KO cells (Figure 1C).
The loss of B7-H1 protein was also confirmed by West- in wt mice), but only a marginal increase was found in
the lung (11.6% in KO mice versus 7.1% in wt mice)ern blot (data not shown). These mice were initially back-
crossed to the C57BL/6 background for at least six gen- (Figure 2B). Our results thus suggest that B7-H1 pre-
vents the accumulation of CD8 T cells in nonhemato-erations before they were used in studies described
below. poietic peripheral organs including the liver and kidney.
To determine the phenotype of accumulated CD8
T cells in the liver of B7-H1 KO mice, we examinedCD8 T Cells that Lack B7-H1 Accumulate
in the Liver the expression of CD62L, CD44, CD25, and CD45RB on
intrahepatic CD8 T cells. A significant fraction of intra-B7-H1 KO mice displayed normal numbers and ratios
of CD4CD8, CD4, and CD8 T cells in the thymus. hepatic CD8 T cells in B7-H1 KO mice were CD62Llow
B7-H1 in Liver CD8 T Cell Apoptosis
329
Figure 2. Selective Accumulation of CD8 T
Cells in the Liver of B7-H1 KO Mice
(A and B) The lymphocytes were isolated from
lymphoid organs (A) and nonlymphoid organs
(B) of wt or KO mice (8–12 weeks old), and
subsequently analyzed by CD4 and CD8 ex-
pression using specific mAbs. The numbers
represent the percentage of CD4, CD8, or
CD4CD8 subsets. One representative re-
sult from six experiments is shown here.
(C) Total cell numbers of CD3, CD4, and
CD8 per liver (n  6) in wt or KO mice are
shown.
in comparison to normal mice (55.9% versus 12.7%) differences were not statistically significant in all three
experiments. Intrahepatic CD8 T cells from B7-H1 KOwhile no difference was found in the lymph nodes of the
same mice (Figure 3A), suggesting that more than half mice demonstrated apoptotic levels comparable to
those from wt mice (data not shown) when further stimu-of these T cells were activated. Similarly, 85.6% of intra-
hepatic CD8 T cells in KO mice were found to be lated in vitro by anti-CD3. Therefore, apoptosis does
not appear to be a dominant mechanism responsibleCD45RBlow compared to 12.3% in wt mice. However,
CD25, a marker for recently activated T cells, was not for the accumulation of CD8 T cells in the liver.
detected in the liver and lymph nodes of KO mice com-
pared to wt mice (Figure 3A). Furthermore, there was Decreased Deletion of Activated T Cells in Liver
of B7-H1 KO Miceno difference in the expression of CD44 in hepatic CD8
T cells between wt and B7-H1 KO mice (Figure 3A) Limited numbers and unknown antigen specificity of
liver CD8 T cells do not allow for detailed functionalthough CD8 T cells appear to be chronically activated
in the liver of B7-H1 KO mice. analyses. To facilitate further analysis, we employed two
well-defined T cell activation models, namely a SEB-To examine whether the accumulation of CD8 T cells
is the result of decreased apoptosis, we stained freshly induced activation/deletion model (Suzuki et al., 2001;
Hildeman et al., 2002; Bonfoco et al., 1998; Kawabe andisolated CD8 T cells from the liver with annexin V. As
shown in Figure 3B, the percentage of apoptotic CD8 Ochi, 1991) and an OT-1 TCR T cell adoptive transfer
system (Mehal et al., 2001). As predicted, i.v. injectionT cells in the liver was consistently lower in B7-H1 KO
mice than in wt mice (42.9% versus 57.2%), but the of SEB superantigen induced a rapid burst of V8.1/
Immunity
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Figure 3. Phenotype of CD8 T Cells in the
Livers versus Lymph Nodes
(A) Lymphocytes isolated from the liver (intra-
hepatic lymphocytes, IHL) or lymph node (LN)
of the same mice were stained with anti-CD8-
Cychrom, CD62L-FITC and anti-CD44-PE
(upper panels), anti-CD8 and anti-CD25 (mid-
dle panel), or anti-CD8 and anti-CD45RB
(lower panels), and subjected to flow cytome-
try analysis. Expression of CD62L and CD44
is shown on the CD8 T cells. The numbers
indicate the percentage of positive staining
in gated CD8 T cells. The data show one
result from four experiments with 8- to 12-
week-old mice.
(B) The freshly isolated IHL from naive mice
were analyzed with anti-CD8 and annexin V.
The open solid line indicates the nonstaining
control. The percentage of apoptotic cells
(annexin V cells) in gated CD8 T cells as
indicated by arrow bar was 57.2% in wt mice
(broken line) and 42.8% in KO mice (dotted
line).
8.2 T cells in both the spleen and liver. Expansion of in the liver of B7-H1 KO mice (11.2% in KO mice versus
49.2% in wt mice) (Figure 5B). Taken together, our re-these cells was found in both CD4 and CD8 popula-
tions. There were no differences in the proliferation of sults indicate that B7-H1 plays a significant role in the
deletion of activated CD8 T cells in the liver. BecauseT cells from the spleen and liver of either wt or B7-H1
KO mice (Figure 4A). Our results thus indicate that the B7-H1 is intact in OT-1 T cells, our results also suggest
that host-derived B7-H1 may be actively involved inexpression of B7-H1 does not affect the proliferative
phase of SEB-stimulated T cells. Following the activa- inducing the apoptosis of activated liver CD8 T cells.
tion/proliferation phase, typically on day 3 or day 4 after
SEB injection, a contraction of activated T cells take Accelerated Experimental Autoimmune Hepatitis
in B7-H1 KO Miceplace, largely due to programmed cell death (Hildeman
et al., 2002; Bonfoco et al., 1998; Kawabe and Ochi, B7-H1 KO mice up to 14 months of age did not have
obvious or microscopically visible pathological changes1991). Interestingly, while the CD4V8.1/8.2 contrac-
tion occurred similarly on day 7 in both the spleen and in the liver and the life span of these mice was similar
to age-matched wt mice. However, accelerated experi-liver of the wt and B7-H1 KO mice, a delay was observed
in the decrease of CD8V8.1/8.2T cells only in the liver mental autoimmune hepatitis was observed in B7-H1
KO mice compared to wt mice (Figures 6A and 6B).of B7-H1 KO mice. The absolute numbers of CD8V8.1/
8.2 T cells also increased in the liver of B7-H1 KO mice In this model, i.v. injection of Con A induced a rapid
activation of T, NK, and NKT cells. The combinationon day 7 after SEB injection (Figure 4B), a time point
when SEB-primed T cells were reduced dramatically by of these cell components led to profound hepatocyte
damage, subsequent release of hepatocyte-specific en-apoptosis (Kawabe and Ochi, 1991). This accumulation
of SEB-activated CD8 V8 T cells in B7-H1KO mice zymes, and the eventual death of the mice (Tiegs et al.,
1992; Kaneko et al., 2000; Takeda et al., 2000; Mizuharawas only found in the liver and not in the kidney or in the
lung (Figure 4B). Furthermore, the reduced apoptosis of et al., 1994). However, we found that NK cell numbers
were in normal ranges while NKT cells were decreasedSEB-activated CD8 V8 T cells in B7-H1 KO mice was
observed in the liver but not in the lymph nodes, kidney, in B7-H1 KO mice (data not shown). One day after the
administration of Con A, the GPT level in serum in-or lung (Figure 4C). These results indicate that B7-H1
selectively deletes activated CD8 T cells in the liver. creased significantly (p  0.05) in the B7-H1 KO mice
compared to wt mice (Figure 6A), indicating hepatocyteThe role of B7-H1 in the deletion of liver CD8 T cells
was further evaluated in an OT-1 TCR transgenic T cell- damage. Furthermore, 40% of B7-H1 KO mice died upon
induction whereas only 10% death was observed in wttransfer system in which wt CD8 OT-1 T cells were
transferred into either wt or B7-H1 KO mice. The mice mice (p 0.05). Pathological evaluation of the liver after
Con A injection revealed extensive necrosis and inflam-were subsequently challenged with OVA peptide. We
observed a significant increase of CD8OT-1 T cells in matory foci consisting of lymphoid and mononuclear
cells and necrotic hepatocytes in both wt and B7-H1the liver of KO mice compared to wt mice on days 5
through 7 post-OVA peptide injection (Figure 5A). KO mice (Figure 6B). However, a more extensive infiltra-
tion of a mixed population of mononuclear cells wasAnnexin V analysis further showed that the apoptotic
level of these CD8OT-1 cells decreased significantly found in B7-H1 KO, and a mixed mononuclear cell infil-
B7-H1 in Liver CD8 T Cell Apoptosis
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Figure 4. Impaired Deletion of SEB-Activated CD8 T Cells in the Liver of B7-H1 KO Mice
(A) After i.v. administration of SEB (100 g/mouse), lymphocytes were isolated from the liver and spleen of wt or KO mice at each time point.
The cells were stained with mAbs to CD4, CD8, and TCR V8.1/8.2. The data show the average percentage of double-positive cells at each
time point from a pool of three mice. *Significantly different from wt mice (p  0.05) on day 7 in six pairs of mice in Student’s t test.
(B) Total numbers of CD8V8.1/8.2 T cells in the liver, kidney, and lung were calculated by multiplying the total lymphocyte numbers from
each organ with the percentage of CD8V8.1/8.2 T cells. The results show the average numbers of three mice at each time point. *Significantly
different from wt mice (p  0.05) on day 7 in six pairs of mice in Student’s t test.
(C) The apoptosis of CD8V8.1/8.2 T cells from lymphoid or nonlymphoid organs on day 4 after the injection of SEB was determined by
annexin V staining. The numbers indicate the average percentage of apoptosis of CD8V8.1/8.2 T cells in the gated areas. *Significantly
different from wt mice in the liver (p  0.002, n  6) but not in the lymph nodes (p  0.625, n  3), the kidney (p  0.401, n  3), and the
lung (p  0.971, n  3).
trate was also detected in and adjacent to the portal the injection of Con A, CD8 T cells increased signifi-
cantly in the liver of B7-H1 KO mice when compared totracts of KO mice (Figure 6B), consistent with the previ-
ous observation that activated T cells preferentially pro- wt mice (22.5% versus 6.2%) while CD4 T cells levels
remained the same or decreased (Figure 6C). Mean-liferate and accumulate in the periportal area of the
liver during the induction of experimental autoimmune while, the activation-induced apoptosis of CD8 T cells
was significantly reduced (from 7.2% to 3.5%) in thehepatitis (Luettig et al., 1999). Interestingly, 1 day after
Immunity
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T cells in both the naive and antigen-primed B7-H1 KO
mice when compared to wt mice, the mechanism for
this observation appears to be different. Increased apo-
ptosis is clearly associated with intrahepatic T cell accu-
mulation after exposure to superantigen or OVA. In con-
trast, no significant apoptosis was found in naive B7-H1
KO mice as indicated by annexin V staining. One poten-
tial interpretation for this observation is hepatitis virus
infection in our mouse colony. We did not, however,
detect any mouse hepatitis virus, nor were there any
signs of infection in the mouse colony during the entire
breeding process for 2 years. B7-H1/ littermates
also had normal cell counts and phenotypes, and there
was no increase of GPT serum levels in B7-H1 KO mice
(Figure 6A), an indicator of hepatocyte damage. In addi-
tion, only CD8, but not CD4, T cells were altered in
B7-H1 KO mice. These observations thus exclude the
potential of infection in these mice. It is possible that
hepatic CD8 T cells in naive mice represent a subset
that respond to self-antigens, undergo apoptosis, and
then are subjected to rapid clearance by liver Kupffer
cells and endothelial cells. It was reported that complete
phagocytosis of apoptotic lymphocytes takes less than
15 min within the liver (Dini, 2000). Because these self-
reactive T cells are relatively small and subject to rapid
elimination, detectable apoptosis of CD8 T cells in na-
ive B7-H1 KO mice may be masked. This interpretation
is also consistent with our observation that a small,
though not significant, decrease of apoptosis could be
Figure 5. Decreased Apoptosis of Activated OT-1 CD8 T Cells in
detected in intrahepatic CD8 T cells in B7-H1 KO micethe Liver of B7-H1 KO Mice
(Figure 3B).(A) Naive OT-1 T cells were transferred into wt or KO mice via i.v.
Several elegant studies by Crispe and colleagues indi-infusion at day 0. OVA peptide was injected i.p. daily for 3 days
cated that systemically delivered antigens promote thefrom day 2. On days 5 and 7 after first OVA peptide injection, the
lymphocytes from the liver and spleen were isolated and stained deletion of activated CD8 T cells in the liver through
with anti-CD8 and Kb/OVA-tetramer. The results represent the aver- apoptosis (Huang et al., 1994; Mehal et al., 2001; Dao
age percentage of CD8 Kb/OVA-tetramer T cells from two to three et al., 2001). Although B7-H1 mRNA is constitutively
mice at each time point from three experiments. expressed in various nonlymphoid tissues, surface pro-(B) On day 5 after first OVA peptide injection, lymphocytes from the
tein expression on these tissues is limited (Dong et al.,liver were isolated and stained with anti-CD8-Cychrom, Kb/OVA-
2002; Selenko-Gebauer et al., 2003; Brown et al., 2003;tetramer-PE, and annexin V-FITC. The percentage of CD8 Kb/OVA-
Iwai et al., 2003). Interestingly, liver Kupffer cells of hu-tetramer T cells in liver lymphocytes from wt or KO mice is shown
in the left panels, and the percentage of annexin V apoptotic cells man (Dong et al., 2002) and mouse (Iwai et al., 2003)
gated on CD8 Kb/OVA-tetramer cells is shown in the right panels. origin constitutively express surface B7-H1 protein.
*Significantly different from that of wt mice (p  0.05, n  5). Nonparenchymal liver cells including Kupffer cells and
sinusoidal endothelial cells inhibited the proliferation of
T cells in vitro (Iwai et al., 2003). The role of these cells
liver of B7-H1 KO mice compared to wt mice (Figure 6C). in the deletion of activated T cells, however, is unknown.
Taken together, our findings suggest that, in the ab- In our experiments, the proliferation and contraction of
sence of B7-H1, the delayed deletion of activated he- V8 T cells upon exposure to SEB superantigen were
patic CD8 T cells accelerates experimental autoim- closely followed. Proliferation of V8 T cells was not
mune hepatitis. affected in the absence of B7-H1. Importantly, the con-
traction phase, which is largely caused by programmed
Discussion cell death (Hildeman et al., 2002; Bonfoco et al., 1998;
Kawabe and Ochi, 1991), was delayed in B7-H1 KO mice.
In this report, we demonstrate that the lack of B7-H1 The role of B7-H1 is specific in intrahepatic CD8 T cells
increases the accumulation of CD8 T cells, but not but not in CD4 T cells, though both CD4 and CD8
CD4 T cells, in the liver of naive B7-H1 KO mice. In T cells were fully activated in this treatment protocol.
addition, antigen-activated CD8 T cells selectively ac- Our data thus designate a unique role for B7-H1 in the
cumulate in the liver, but not in the kidney and lung, of deletion of CD8 T cells in the liver. In our OT-1 system,
B7-H1 KO mice. These mice are also more vulnerable OT-1 transgenic TCR CD8 T cells were transferred into
to the induction of experimental autoimmune hepatitis. mice and again activated in vivo by administration of
Our results indicate that B7-H1 is an important molecule OVA peptide. Upon immunization, the accumulation and
in controlling the deletion of activated intrahepatic CD8 decreased apoptosis of activated OT-1 T cells were also
T cells. found in the liver of B7-H1 KO mice, similar to SEB
stimulation. Because transferred OT-1 T cells have nor-Although there was a greater accumulation of CD8
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mal B7-H1 expression, our results suggest that host-
derived but not T cell-associated B7-H1 plays a critical
role in these deletion processes. Taken together, our
findings suggest that B7-H1 on liver nonparenchymal
cells plays a role in the deletion of activated T cells.
Though the mechanism of T cell apoptosis in B7-H1
deficient mice is unknown., the Fas pathway is believed
to play a critical role in the deletion of activated T cells
in the peripheral organs (Krueger et al., 2003; Green et
al., 2003). While Fas is important for the apoptosis of
CD4 T cells, its role in the depletion of CD8 T cells in
peripheral organs is unclear (Ehl et al., 1996; Suzuki and
Fink, 2000). For example, in the Fas-defective lpr mice,
the deletion and accumulation of TCR transgenic CD8
T cells in the lymph nodes and liver are within the normal
range (Mehal and Crispe, 1998). In an adenovirus infec-
tion mouse model, however, deletion of activated CD8
T cells in the liver is dependent on the Fas pathway (Liu
et al., 2001).
The relationship between B7-H1 and Fas in liver CD8
T cell depletion is unknown. In these lpr mice, the Fas
defect led to the appearance of B220CD4CD8TCR
	 (DN) T cells in the liver and in the peripheral lymphoid
tissues, particularly the lymph nodes (Davidson et al.,
1986; Adachi et al., 1996). We did not observe increased
DN T cells in the liver or in the lymph nodes of B7-H1
KO mice. In addition, we also found that the expression
of Fas and FasL on the surface of CD8 T cells did
not change in naive B7-H1 KO mice (unpublished data).
These data suggest that B7-H1 regulates the accumula-
tion of naive CD8 T cells in the liver through a Fas-
independent pathway. Deletion of activated CD8T cells
by B7-H1, however, appears to be at least partially medi-
ated by Fas. We previously showed that B7-H1 costim-
ulation enhanced the expression of Fas and FasL on
activated T cells, partially contributing to T cell death
(Dong et al., 2002). Moreover, the decreased apoptosis
of CD8 T cells in SEB-treated B7-H1 KO mice was in
concert with the decreased expression of Fas and FasL
on their surface (unpublished data). Our data thus sup-
port that B7-H1 has distinct roles in controlling the accu-
mulation of naive CD8 T cells and the deletion of acti-
vated CD8 T cells in the liver.
In addition to the liver, the lack of B7-H1 also in-
creased the accumulation of CD8 T cells in the kidneys
of naive B7-H1 KO mice (Figure 2B). An increase, though
not statistically significant, of CD8 T cells in the lung,
was also observed. However, the accumulation of SEB-
activated CD8V8T cells in B7-H1KO mice was found
only in the liver but not in the kidney and lung (FigureFigure 6. Accelerated Experimental Autoimmune Hepatitis in B7-
H1 KO Mice 4B). In addition, apoptosis of SEB-activated CD8T cells
(A) The GPT levels were detected in the sera of wt or KO mice 1 in B7-H1 KO mice was reduced in the liver but not in
day after the injection of Con A at 20 mg/kg or of PBS as control. the lymph nodes, kidney, and lung (Figure 4C). From
The results represent the average GPT levels (OD value) from five these observations, the role of B7-H1 in the deletion of
mice in each group. activated CD8 T cells is specific to the liver.
(B) Liver tissue sections (40
) from wt or KO mice were stained with
The selective role of B7-H1 on CD8 T cells in non-hematoxylin and eosin on day 1 after the injection of Con A. C,
central vein; P, portal vein. Arrows indicated the infiltration of mono-
nuclear cells. The average nodules of periportal vein lymphocyte
infiltrates in 20 randomly selective view fields (
10) by double blind
method in KO mice were 3.1  1.3 and in wt mice were 1.5  0.6 of CD4or CD8T cell subset (upper panels). Cells were also stained
(p  0.01, n  5). with annexin V, and the numbers represent the percentage of
(C) The lymphocytes were isolated from the liver 1 day after the annexin V cells in gated CD8 T cells (lower panels). One represen-
injection of Con A at 12 mg/kg. The cells were stained with anti- tative result from two independent experiments is shown. *Signifi-
CD4 and anti-CD8 mAbs. The numbers represent the percentage cantly different from that of wt mice (p  0.01, n  5).
Immunity
334
by Southern blot analysis using a 3 EcoRI/XhoI external probe. Inlymphoid organs remains to be explored. Constitutive
addition, three different primers were used to amplify a 250 bpexpression of B7-H1 was found in monocyte-derived
fragment from the wt allele or a 450 bp fragment from the mutantcells, a population enriched in the liver, kidneys, and
allele. PCR (30 cycles) was carried out using the following primers:
lung. However, B7-H1 could be rapidly upregulated by forward B7-H1 primer, 5-AGAACGGGAGCTGGACCTGCTTGCGT
proinflammatory cytokines such as IFN- in various tis- TAG-3; reverse B7-H1 primer, 5-ATTGACTTTCAGCGTGATTCGC
TTGTAG-3; Neo primer, 5-TTCTATCGCCTTCTTGACGAGTTCTTsues and cells (Dong and Chen, 2003; Yamazaki et al.,
CTG-3. Chimeric males were crossed with C57BL/6 females, and2002). Therefore, the expression pattern of B7-H1 can-
agouti F1 offspring were screened for the mutant B7-H1 allele bynot fully explain its selective effect. B7-H1 is found to
PCR. Homozygous targeted mice were derived by crossing F1 het-engage at least two receptors, the inhibitory receptor
erozygous mice and screened by PCR and/or Southern blot. The
PD-1 (Freeman et al., 2000) which can be induced in mice were backcrossed to C57BL/6 background for at least six
both CD4 and CD8 T cells (Carter et al., 2002) and, generations before experimental analysis.
as of yet, an unidentified costimulatory receptor (Dong
et al., 2002; Wang et al., 2003). In a recent study, i.v. Isolation of Lymphocytes from Peripheral Organs
Lymphocytes from liver, lungs, and kidneys were purified as pre-injection of adenovirus induced an extensive expan-
viously reported (Mehal et al., 2001; Dao et al., 2001) with smallsion of both intrahepatic CD4 and CD8 T cells in
modifications. In brief, the organs were first flushed with PBS,PD-1-deficient mice that was absent in wt mice, sug-
chopped into fine particles, and then incubated in 10 ml of digestion
gesting that PD-1 inhibits the total T cell response (Iwai buffer (5% of FBS, 0.02% of collagenase IV, 10 U of heparin, 0.002%
et al., 2003). In this study, however, it is unknown of DNase I in RPMI 1640 medium) for 40 min in a 37C water bath.
After a brief spinning down of the undigested particles, the fractionswhether this effect is caused by a decrease of apoptosis.
containing lymphocytes were collected by centrifuging the suspen-We observed that the B7-H1-mediated apoptosis of hu-
sion for 10 min at 2000 rpm. To purify the lymphocytes, the cellman CTL could not be consistently abrogated by a de-
pellet was suspended in 1 ml of RPMI 1640 medium with 10% ofcoy PD-1 receptor (Dong et al., 2002). There was no
FBS, mixed with 4 ml of 30% Metrizamide (Cedarlane, Inc., Ontario,
significant delay in the contraction phase of SEB-acti- Canada) solution, and then layered under 2 ml of serum-free Hank’s
vated CD4 and CD8 T cells in PD-1 KO mice. In addi- buffer. After centrifuging at 2600 rpm for 20 min at 4C, lymphocytes
were collected from the interface, washed twice with PBS, andtion, there was no significant decrease of apoptosis in
counted before flow cytometry analysis.both activated CD4 and CD8 T cells in the liver of
PD-1 KO mice (unpublished data). These data suggest
Flow Cytometry Analysisthat the deleterious effect of B7-H1 on intrahepatic CD8
The phenotypes of lymphocytes were analyzed with flow cytometryT cells is mediated through a receptor other than PD-1.
by using a set of monoclonal antibodies including anti-CD3 (145-
B7-H1-deficient mice did not develop spontaneous 2C11), anti-CD4 (H129.19), anti-CD8 (53-6.7), anti-CD62L (MEL-14),
liver diseases, though a significant accumulation of acti- anti-CD44 (IM7), anti-CD25 (PC61), and anti-CD45RB (16A). All these
antibodies were purchased from Becton Dickinson (BD) Pharmingenvated CD8 T cells in the liver was observed. However,
(San Diego, CA). The expression of B7-H1 on activated T cells wasaccelerated hepatocyte destruction occurred in these
detected with hamster anti-mouse B7-H1 monoclonal antibodymice after inducing experimental autoimmune hepatitis,
(10B5) as previously reported (Tamura et al., 2001; Dong et al., 2002).accompanied with an increased infiltration of mononu-
After a brief blocking of the mouse FcR with nonlabeled antibodies,
clear cells and decreased apoptosis of CD8 T cells in the cells were stained with the specific antibodies in PBS with 3%
the liver, suggesting that decreased apoptosis may be of FBS for 30 min at 4C. The binding of antibodies was detected
with the FACScan flow cytometer (BD) and analyzed with CellQuestresponsible for the increased accumulation of T cells
software (BD, Mountain View, CA).and the more severe hepatocyte damage detected in
the absence of B7-H1. However, other mechanisms,
In Vivo Activation of T Cellsincluding altered cytokine production and the migratory
Mice were injected intravenously (i.v.) with 100 g of staphylococcalcapacity of T cells, could not be completely excluded.
enterotoxin B (SEB, Toxin Technology, Sarasota, FL) on day 0. On
Nevertheless, this study reveals a novel function of days 3, 5, and 7, the lymphocytes from the spleen, lymph nodes,
B7-H1 in the control of CD8 T cell accumulation and and liver were harvested and stained with fluorescent isothiocynate
(FITC)-conjugated anti-TCR V 8.1/8.2, phycoerythrin (PE)-conju-deletion, preferentially in the liver. Our findings implicate
gated anti-CD8, and Cy-Chrome-conjugated anti-CD4 mAb (BDa role of B7-H1 in liver inflammation, autoimmune re-
Pharmingen). The percentages of V8.1/8.2 cell in CD4 or CD8sponses, and tolerance and may open up new approaches
subsets were detected by flow cytometry.for the therapeutic manipulation of liver diseases.
The method to detect OT-1 TCR transgenic T cells in the liver
was reported previously (Mehal et al., 2001; Sica et al., 2003). In
brief, two million purified CD8 T cells from OT-1 TCR transgenicExperimental Procedures
mice were injected i.v. into wt or B7-H1 KO mice on day 0. Two
days later, the mice were given three daily injections of 24 g OVAGeneration of B7-H1 KO Mice
peptide (SIINFEKL). On days 7 and 9, the lymphocytes from theA phage clone containing 11.3 kb of the mouse B7-H1 genomic
liver and spleen were isolated, counted, and stained with anti-CD8-DNA was identified from the E14 129Sv/E phage genomic DNA
CyChrome (53-6.7) and Kb/OVA-tetramer-PE (Beckman Coulter, Fuller-library by Southern blot using B7-H1 cDNA as the probe. Exon 1
ton, CA). Apoptosis of CD8 OT-1 T cells was analyzed by stainingwith the ATG start code was identified in this clone by PCR using
with annexin V-FITC (BD).primers based on the murine B7-H1 cDNA. Using the pKO Scrambler
NTKV-1907 vector (Stratagene) as the backbone, we constructed a
B7-H1 targeting vector containing an 8 kb B7-H1 genomic DNA Model of Experimental Autoimmune Hepatitis
Wt and B7-H1 KO mice at 12–16 weeks old were injected i.v. withfragment. Within this fragment, a 1.4 kb SpeI/PstI fragment con-
taining the exon/intron 1 (encoding amino acids 1–17) and part of an optimal dose (20 mg/kg) or suboptimal dose (12 mg/kg) of Con
A (Chen et al., 2001). One day after the administration of Con A, thethe exon 2 (encoding amino acids 18–106) of B7-H1 were replaced
by PGK-Neo cassette. The targeting construct was then transfected serum GPT (glutamic-pyruvic transaminase) levels in the mouse sera
were detected with the GPT detection kit (Sigma, St. Louis, MO).into 129Sv/E embryonic stem (ES) cells, and the cells underwent
neomycin drug selection. Targeted ES cell clones were identified The livers were removed, fixed in formalin solution, and embedded
B7-H1 in Liver CD8 T Cell Apoptosis
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in paraffin. The liver sections were stained with hematoxylin and member of the B7 family, co-stimulates T-cell proliferation and in-
terleukin-10 secretion. Nat. Med. 5, 1365–1369.eosin for morphological study. The lymphocytes from liver were
isolated 1 day after the administration of a suboptimal dose of Con Dong, H., Strome, S.E., Salomao, D.R., Tamura, H., Hirano, F., Flies,
A, stained with mAb to CD4 and CD8, and then stained with annexin D.B., Roche, P.C., Lu, J., Zhu, G., Tamada, K., et al. (2002). Tumor-
V to analyze the profile of T cells and their apoptotic levels by flow associated B7-H1 promotes T-cell apoptosis: a potential mecha-
cytometry (Dong et al., 1999). nism of immune evasion. Nat. Med. 8, 793–800.
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